563
Views
2
CrossRef citations to date
0
Altmetric
PSYCHOTHERAPEUTICS COLUMN

Vortioxetine (Brintellix®) and Levomilnacipran (Fetzima®): The Two Newest Additions to the Antidepressant Formulary

, PhD, RN, PMHCNS-BC & , MSN, RN
Pages 972-974 | Published online: 26 Nov 2014
 

Abstract

In the final months of 2013, the US Food and Drug Administration approved two new antidepressant formulations. This column presents a review of the pertinent literature on both: vortioxetine (Brintellix®) and levomilnacipran (Fetzima®).

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 304.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.